Ampio Pharmaceuticals, Inc. filed its 10-K on Mar 27, 2023 for the period ending Dec 31, 2022. In this report its auditor, Moss Adams LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 USD | -8.94% | -18.52% | -89.27% |
Apr. 15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
Mar. 27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-89.27% | 250K | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.26% | 21.6B | |
-12.38% | 22.31B | |
-5.71% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- AMPE Stock
- News Ampio Pharmaceuticals, Inc.
- Ampio Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt